0.2 mg compounded semaglutide Hims & Hers stock falls 25% as FDA curtails GLP-1s FDA warns about compounded versions

Obesity often requires a comprehensive treatment approach, said Norris

Tirzepatide has a different mechanism and higher potency

Key Takeaways Metformin and GLP-1 agonists work synergistically to improve insulin response, reduce appetite, and support sustainable weight loss

Discussion As diets high in protein are theoretically advantageous for patients with T2D and obesity due to their satiating properties compared with carbohydrate- and lipid-rich meals [25,26,27], specific amino acids selected for their appetite-reducing and GLP-1 stimulating effect may represent an approach for nutritionally based modulation of GLP-1 secretion